|
New to PCSK9 Forum
ESC Congress 2021, 27-30 August, Virtual Meeting
What made the lipid news at this year’s virtual congress? PCSK9 Forum covered the latest late breaking news and clinical sessions, as well as insights from key poster presentations.
|
|
|
 |
|
Treatment with evolocumab favourably modified plaque phenotype, suggesting stabilization of vulnerable plaque after acute coronary syndrome.
Read the report »
Prof Steve Nicholls (Monash University, Melbourne, Australia) discusses HUYGENS.
Watch the video »
|
|
 |
|
Earlier reduction in LDL cholesterol provides greater lifetime benefit, according to results of this naturally randomized ‘target’ trial, presented by Prof Brian Ference (University of Cambridge, Cambridge, UK).
Read the report »
|
|
 |
|
Inclisiran was similarly effective in patients with polyvascular disease or cerebrovascular disease, according to the latest subgroup analyses.
Read the report »
Prof Derick Raal (University of the Witwatersrand, Johannesburg, South Africa) discusses the clinical implications from these ORION analyses.
Watch the video »
|
|
|
For the latest updates, PCSK9 news and analysis. |
|
Hot topics, news and conference reports. |
|
For videos, interviews and webcasts from leading experts. |
|
|
|
|
|
|
Educational Partners
and Supporters |
 |
|
 |
|
 |
|
|
|
| Copyright PCSK9 Forum 2021.
Please click here to unsubscribe from future mailings.. View on the web |
|
